Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for RGEDF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
March 31, 2026 5.255B
December 31, 2025 5.195B
September 30, 2025 4.951B
June 30, 2025 4.702B
March 31, 2025 4.363B
December 31, 2024 4.046B
September 30, 2024 4.178B
June 30, 2024 3.959B
March 31, 2024 3.898B
December 31, 2023 3.934B
September 30, 2023 3.701B
June 30, 2023 3.699B
March 31, 2023 3.912B
December 31, 2022 3.608B
September 30, 2022 3.207B
June 30, 2022 3.391B
March 31, 2022 3.557B
December 31, 2021 3.534B
September 30, 2021 3.593B
June 30, 2021 3.516B
March 31, 2021 3.136B
December 31, 2020 3.200B
September 30, 2020 3.001B
June 30, 2020 2.875B
March 31, 2020 2.686B
Date Value
December 31, 2019 2.914B
September 30, 2019 2.871B
June 30, 2019 3.009B
March 31, 2019 2.930B
December 31, 2018 2.843B
September 30, 2018 2.941B
June 30, 2018 2.865B
March 31, 2018 3.059B
December 31, 2017 2.945B
September 30, 2017 3.129B
June 30, 2017 3.005B
March 31, 2017 2.855B
December 31, 2016 2.766B
September 30, 2016 2.840B
June 30, 2016 2.725B
March 31, 2016 2.744B
December 31, 2015 2.575B
September 30, 2015 2.686B
June 30, 2015 2.667B
March 31, 2015 2.649B
December 31, 2014 2.759B
September 30, 2014 3.025B
June 30, 2014 3.288B
March 31, 2014 3.255B
December 31, 2013 3.323B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
AstraZeneca PLC 114.02B
ANI Pharmaceuticals, Inc. 1.422B
Corcept Therapeutics, Inc. 814.88M
Assertio Holdings, Inc. 211.30M
Veru, Inc. 43.08M

Total Assets (Quarterly) Related Metrics